BBC reports on efforts to broaden access to childhood vaccines

The BBC reports on discussions about childhood immunization at the International Pediatric Association (IPA) meeting last week in Johannesburg, South Africa. "Vaccines are a key plank in meeting Millennium Development Goal 4 - to reduce child mortality by two thirds by 2015 - and many sessions at the congress were devoted to them," the news service writes.

The article explores several challenges associated with delivering vaccines to children throughout the world, including "[l]ogistics, infrastructure and political will," and notes how experts are rethinking systems for delivering vaccines in developing countries to help reduce waste and maximize the number of children reached.

The story looks at efforts to broaden access to "the pentavalent vaccine, a five in one shot containing tetanus, diphtheria, pertussis, hepatitis B and Haemophilus influenzae type B vaccine (Hib)," including by a one-use, pre-filled injection that "health workers with less than two hours of training" can use to immunize children. The article includes comments from IPA Executive Director Jane Schaller and Simona Zipursky of Project Optimise, "a WHO collaboration with PATH developing immunisation systems for tomorrow's world" (Parry, 8/16).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Late-liver-stage malaria vaccine delivers 89% protection and boosts cellular immunity